Perigon Wealth Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-61,093
| Closed | -$73K | – | 730 |
|
|
2022
Q3 | $73K | Sell |
61,093
-478
| -0.8% | -$571 | 0.01% | 559 |
|
|
2022
Q2 | $111K | Hold |
61,571
| – | – | 0.01% | 548 |
|
|
2022
Q1 | $124K | Buy |
61,571
+35,000
| +132% | +$70.5K | 0.01% | 582 |
|
|
2021
Q4 | $72K | Buy |
26,571
+800
| +3% | +$2.17K | 0.01% | 570 |
|
|
2021
Q3 | $115K | Hold |
25,771
| – | – | 0.01% | 522 |
|
|
2021
Q2 | $149K | Buy |
25,771
+771
| +3% | +$4.46K | 0.01% | 504 |
|
|
2021
Q1 | $176K | Buy |
+25,000
| New | +$176K | 0.02% | 477 |
|
|
2018
Q2 | – | Sell |
-728
| Closed | -$38K | – | 643 |
|
|
2018
Q1 | $38K | Buy |
728
+30
| +4% | +$1.57K | 0.01% | 349 |
|
|
2017
Q4 | $47K | Hold |
698
| – | – | 0.02% | 302 |
|
|
2017
Q3 | $58K | Buy |
+698
| New | +$58K | 0.02% | 318 |
|